Trial Profile
A Phase I Randomized, Open-label, 3-arm Parallel-design Study to Determine the Effect of Multiple-dose Gemfibrozil or Itraconazole on the Pharmacokinetics, Safety and Tolerability of Single-dose MDV3100 (ASP9785) in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Enzalutamide (Primary) ; Gemfibrozil; Itraconazole
- Indications Breast cancer; Hyperlipidaemia; Prostate cancer
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 07 Aug 2013 New trial record